The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing.

Background: This PRONTO study investigated the clinical performance of the Abbott ID NOW (IDN) COVID-19 diagnostic assay used at point of care and its impact on turnaround time for divulgation of test results.

Methods: Prospective study conducted from December 2020 to February 2021 in acute symptomatic participants presenting in three walk-in centres in the province of Québec.

Results: Valid paired samples were obtained from 2,372 participants.